Marshall Wace
IDYA icon

Marshall Wace’s IDEAYA Biosciences IDYA Stock Holding History

Marshall Wace’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-312,666
Closed -$8.04M – 2835
2024
Q4 		$8.04M Buy
312,666
+60,361
+24% +$1.71M 0.01% 879
2024
Q3 		$7.99M Buy
252,305
+153,494
+155% +$5.82M 0.01% 841
2024
Q2 		$3.47M Sell
98,811
-11,540
-10% -$457K ﹤0.01% 1144
2024
Q1 		$4.84M Buy
+110,351
New +$4.74M 0.01% 1012
2023
Q2 		– Sell
-27,903
Closed -$383K – 2675
2023
Q1 		$383K Buy
+27,903
New +$465K ﹤0.01% 2210
2022
Q4 		– Sell
-11,055
Closed -$166K – 3155
2022
Q3 		$166K Buy
+11,055
New +$144K ﹤0.01% 3124
2022
Q2 		– Sell
-166,805
Closed -$1.87M – 3627
2022
Q1 		$1.87M Buy
166,805
+163,482
+4,920% +$2.41M ﹤0.01% 2105
2021
Q4 		$79K Buy
+3,323
New +$77.2K ﹤0.01% 3444
2021
Q2 		– Sell
-10,160
Closed -$239K – 2834
2021
Q1 		$239K Buy
+10,160
New +$196K ﹤0.01% 2203
2020
Q3 		– Sell
-27,228
Closed -$388K – 1739
2020
Q2 		$388K Buy
+27,228
New +$215K ﹤0.01% 1264

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Marshall Wace's IDYA Position: Q1 2025 in Review

Marshall Wace sold out of IDEAYA Biosciences (IDYA) in Q1 2025, closing a stake of 312,666 shares — an estimated $8.04M sold.

Marshall Wace first reported a position in IDYA in Q2 2020 and held it in 10 quarters. The position peaked at $8.04M in Q4 2024. 207 funds tracked by Wall St. Rank hold IDYA as of Q1 2025.

  • Marshall Wace reported no remaining IDEAYA Biosciences position as of Q1 2025 after selling out during the quarter.
  • Marshall Wace sold 312,666 IDEAYA Biosciences shares in Q1 2025, an estimated $8.04M.
  • Marshall Wace first reported a position in IDEAYA Biosciences in Q2 2020 and held it in 10 quarters.
  • Marshall Wace's IDEAYA Biosciences position peaked at $8.04M in Q4 2024.
  • 207 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2025.

Based on Marshall Wace's 13F filing for Q1 2025, filed 15 May 2025.